Frits van Rhee
Impact in
- Hematology top 0.02%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Oncology top 0.2%
- Peptidase Inhibition and Analysis
- Viral-associated cancers and disorders
Papers in
- Hematology 302
- Multiple Myeloma Research and Treatments 251
- Hematopoietic Stem Cell Transplantation 44
- Oncology 189
- Viral-associated cancers and disorders 60
- Peptidase Inhibition and Analysis 45
- Cancer Treatment and Pharmacology 40
- Co-authors
- Bart BarlogieJohn D. ShaughnessyJohn CrowleyGuido TricotMaurizio ZangariElias AnaissieJoshua EpsteinMauricio Pineda‐Roman
- Journals
- Blood (176 papers)Journal of Clinical Oncology (36 papers)British Journal of Haematology (25 papers)Bone Marrow Transplantation (20 papers)Haematologica (11 papers)
- Partner nations
- United StatesUnited KingdomJordan
In The Last Decade
Frits van Rhee
395 papers receiving 13.8k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Hematology 9.9k
- Oncology 6.4k
- Genetics 2.0k
- Immunology 2.1k
- Molecular Biology 6.6k
Countries citing papers authored by Frits van Rhee
This map shows the geographic impact of Frits van Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frits van Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frits van Rhee more than expected).
Fields of papers citing papers by Frits van Rhee
This network shows the impact of papers produced by Frits van Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frits van Rhee. The network helps show where Frits van Rhee may publish in the future.
Co-authors
The 25 scholars most cited alongside Frits van Rhee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 2 | |
| 12 | 2018 | 27 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 92 | |
| 15 | 2014 | 169 | |
| 16 | 2013 | 166 | |
| 17 | 2012 | 13 | |
| 18 | 2010 | 103 | |
| 19 | 2009 | 142 | |
| 20 | 2007 | 75 |
About Frits van Rhee
Frits van Rhee is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 421 papers that have together received 14.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (251 papers), Protein Degradation and Inhibitors (93 papers), Viral-associated cancers and disorders (60 papers), Lymphoma Diagnosis and Treatment (56 papers), Peptidase Inhibition and Analysis (45 papers), Hematopoietic Stem Cell Transplantation (44 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Cancer Treatment and Pharmacology (40 papers). The work is most often cited by research in Hematology (9.9k citations), Oncology (6.4k citations), Genetics (2.0k citations), Immunology (2.1k citations) and Molecular Biology (6.6k citations). Frits van Rhee has collaborated with scholars based in United States, United Kingdom and Jordan. Frequent co-authors include Bart Barlogie, John D. Shaughnessy, John Crowley, Guido Tricot, Maurizio Zangari, Elias Anaissie, Joshua Epstein, Mauricio Pineda‐Roman, Klaus Hollmig and Fenghuang Zhan. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Bone Marrow Transplantation and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.